Medpace Holdings, Inc. Reports Second Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Medpace (MEDP) PT Raised to $31 at Jefferies; Remains Sidelined
August 2, 2017 8:59 AM EDTJefferies raised its price target on Medpace (NASDAQ: MEDP) to $31.00 (from $30.00) while maintaining a Hold rating. Bad debt was reduced/avoided, and bookings improved sequentially. EBITDA guidance post 1Q17 ($106-108M) included $2-3M of bad debt exposure expected to hit the... More
